Goldstein Advisors »

Xeris Pharmaceuticals shares owned by Goldstein Advisors

Quarter-by-quarter ownership of Xeris Pharmaceuticals (XERS) shares owned by Goldstein Advisors from 13F filings

Historical chart of Goldstein Advisors investment in Xeris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xeris Pharmaceuticals held by Goldstein Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xeris Pharmaceuticals by Goldstein Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $60k 25k 2.35
2023-09-30 $47k 25k 1.86
2023-06-30 $67k 25k 2.62
2023-03-31 $41k 25k 1.63
2022-12-31 $21k 15k 1.36

More positions owned by Goldstein Advisors

Ishares Tr Core S&p Ttl Stk (ITOT)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Victory Portfolios Ii Core Intermediat (UITB)
Goldman Sachs Etf Tr Acces Treasury (GBIL)
Litman Gregory Fds Tr Imgp Dbi Managed (DBMF)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Pimco Etf Tr Active Bd Etf (BOND)
J P Morgan Exchange Traded F Diversfed Rtrn (JPME)
J P Morgan Exchange Traded F Equity Premium (JEPI)
American Centy Etf Tr Diversified Mu (TAXF)
J P Morgan Exchange Traded F Active Growth (JGRO)
Hartford Fds Exchange Traded Mun Oportunite (HMOP)
Franklin Templeton Etf Tr Intl Cor Div Til (DIVI)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Ishares Tr Core Msci Total (IXUS)

View all positions for Goldstein Advisors

Top funds holding Xeris Pharmaceuticals

Vanguard Group
Rosalind Advisors
Millennium Management
D. E. Shaw & Co
Redmile Group
Citadel Advisors
Invenomic Capital Management
Tudor Investment Corporation
GSA Capital Partners
Lazard Asset Management
Charles Schwab Investment Management
Bank of New York Mellon
Jpmorgan Chase & Co
Barclays
AQR Capital Management

View all funds holding Xeris Pharmaceuticals